RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Antonei Benjamin Csoka to Hyaluronoglucosaminidase

This is a "connection" page, showing publications Antonei Benjamin Csoka has written about Hyaluronoglucosaminidase.
  1. Csoka AB, Frost GI, Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 2001 Dec; 20(8):499-508.
    View in: PubMed
    Score: 0.205
  2. Cs?ka AB, Scherer SW, Stern R. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics. 1999 Sep 15; 60(3):356-61.
    View in: PubMed
    Score: 0.176
  3. Cs?ka AB, Frost GI, Heng HH, Scherer SW, Mohapatra G, Stern R, Cs?ka TB. The hyaluronidase gene HYAL1 maps to chromosome 3p21.2-p21.3 in human and 9F1-F2 in mouse, a conserved candidate tumor suppressor locus. Genomics. 1998 Feb 15; 48(1):63-70.
    View in: PubMed
    Score: 0.158
  4. Cs?ka AB, Frost GI, Wong T, Stern R, Cs?ka TB. Purification and microsequencing of hyaluronidase isozymes from human urine. FEBS Lett. 1997 Nov 17; 417(3):307-10.
    View in: PubMed
    Score: 0.155
  5. Cs?ka TB, Frost GI, Stern R, Cs?ka AB. Hyaluronidases in tissue invasion. Invasion Metastasis. 1997; 17(6):297-311.
    View in: PubMed
    Score: 0.146
  6. Csoka AB, Stern R. Hypotheses on the evolution of hyaluronan: a highly ironic acid. Glycobiology. 2013 Apr; 23(4):398-411.
    View in: PubMed
    Score: 0.111
  7. Martin DC, Atmuri V, Hemming RJ, Farley J, Mort JS, Byers S, Hombach-Klonisch S, Csoka AB, Stern R, Triggs-Raine BL. A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis. Hum Mol Genet. 2008 Jul 01; 17(13):1904-15.
    View in: PubMed
    Score: 0.079
  8. Shuster S, Frost GI, Csoka AB, Formby B, Stern R. Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int J Cancer. 2002 Nov 10; 102(2):192-7.
    View in: PubMed
    Score: 0.055
  9. Nicoll SB, Barak O, Cs?ka AB, Bhatnagar RS, Stern R. Hyaluronidases and CD44 undergo differential modulation during chondrogenesis. Biochem Biophys Res Commun. 2002 Apr 12; 292(4):819-25.
    View in: PubMed
    Score: 0.053
  10. Nawy SS, Cs?ka AB, Mio K, Stern R. Hyaluronidase activity and hyaluronidase inhibitors. Assay using a microtiter-based system. Methods Mol Biol. 2001; 171:383-9.
    View in: PubMed
    Score: 0.048
  11. Mio K, Cs?ka AB, Nawy SS, Stern R. Detecting hyaluronidase and hyaluronidase inhibitors. Hyaluronan-substrate gel and -inverse substrate gel techniques. Methods Mol Biol. 2001; 171:391-7.
    View in: PubMed
    Score: 0.048
  12. Frost GI, Mohapatra G, Wong TM, Cs?ka AB, Gray JW, Stern R. HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA. Oncogene. 2000 Feb 17; 19(7):870-7.
    View in: PubMed
    Score: 0.045
  13. Laugier JP, Shuster S, Rosdy M, Cs?ka AB, Stern R, Maibach HI. Topical hyaluronidase decreases hyaluronic acid and CD44 in human skin and in reconstituted human epidermis: evidence that hyaluronidase can permeate the stratum corneum. Br J Dermatol. 2000 Feb; 142(2):226-33.
    View in: PubMed
    Score: 0.045
  14. Stair-Nawy S, Cs?ka AB, Stern R. Hyaluronidase expression in human skin fibroblasts. Biochem Biophys Res Commun. 1999 Dec 09; 266(1):268-73.
    View in: PubMed
    Score: 0.045
  15. Frost GI, Cs?ka AB, Wong T, Stern R, Cs?ka TB. Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun. 1997 Jul 09; 236(1):10-5.
    View in: PubMed
    Score: 0.038
  16. Gordon LB, Harten IA, Calabro A, Sugumaran G, Csoka AB, Brown WT, Hascall V, Toole BP. Hyaluronan is not elevated in urine or serum in Hutchinson-Gilford Progeria Syndrome. Hum Genet. 2003 Jul; 113(2):178-87.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support